Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Number of holders
-
249
-
Total 13F shares, excl. options
-
93,092,725
-
Shares change
-
+2,985,931
-
Total reported value, excl. options
-
$1,656,135,243
-
Value change
-
+$59,195,672
-
Put/Call ratio
-
79%
-
Number of buys
-
135
-
Number of sells
-
97
-
Price
-
$17.79
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q2 2024
As of 30 Jun 2024 TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) had 249 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 93,092,725 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Soleus Capital Management, L.P., Pictet Asset Management Holding SA, GEODE CAPITAL MANAGEMENT, LLC, Deep Track Capital, LP, Opaleye Management Inc., GOLDMAN SACHS GROUP INC, and BANK OF AMERICA CORP /DE/.
This table shows 249 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.